...
首页> 外文期刊>Endocrine Connections >The relationship between insulin sensitivity and serum antithrombin 3 activity in patients with type 2 diabetes
【24h】

The relationship between insulin sensitivity and serum antithrombin 3 activity in patients with type 2 diabetes

机译:2型糖尿病患者胰岛素敏感性与血清抗抗凝血酶3活性的关系

获取原文

摘要

Background Antithrombin 3 (AT3) is a physiological inhibitor of thrombin, and serum AT3 activity was found to decrease at the status of type 2 diabetes (T2D). T2D was presented with an increased risk of thrombotic complications at the background of impaired insulin sensitivity. The aim of this study was to investigate the relationship between insulin sensitivity indices and serum AT3 activity in patients with T2D. Methods We conducted a cross-sectional study in patients with T2D who consented to participate in the study at the Endocrinology Department of Affiliated 2 Hospital of Nantong University from January 2015 to June 2018. All patients received serum AT3 activity test and 75 g oral glucose tolerance test (OGTT). Basal and systemic insulin sensitivity were assessed by homeostasis model assessment of insulin resistance (HOMA-IR) and Matsuda index (ISI _(Matsuda)), respectively, from the OGTT. And other relevant clinical data were also collected. Results Total of 1612 patients with T2D were enrolled in the study, with a mean age of 58.67 ± 13.09 years and a median diabetes duration of 6 years (interquartile range, 1–10 years). Across ascending quartiles of serum AT3 activity, HOMA-IR progressively decreased, while ISI _(Matsuda) progressively increased (all P for trend & 0.001). Moreover, serum AT3 activity was negatively correlated with HOMA-IR ( r = ?0.189 , P & 0.001) and positively correlated with ISI _(Matsuda) ( r = 0.221 , P & 0.001). After adjusting for other metabolic risk factors, hemostatic parameters and glucose-lowering therapies by multivariate linear regression analysis, HOMA-IR ( β = ?0.185, t = ?5.960 , P & 0.001) and ISI _(Matsuda) ( β?=? 0.197 , t = 6.632 , P & 0.001) remained independently associated with the serum AT3 activity in patients with T2D, respectively. Conclusions Reduced basal and systemic insulin sensitivity are associated with decreased serum AT3 activity in patients with T2D.
机译:背景技术抗凝血酶3(AT3)是凝血酶的生理抑制剂,并且发现血清AT3活性在2型糖尿病(T2D)的状态下降低。在胰岛素敏感性受损的背景下,T2D的风险增加了血栓形成的风险。本研究的目的是探讨T2D患者胰岛素敏感性指数与血清AT3活性的关系。方法对T2D患者进行了横断面研究,他同意从2015年1月到2018年6月参加南通大学附属2医院内分泌学系的研究。所有患者均接受血清AT3活性试验和75克口服葡萄糖耐量测试(OGTT)。通过胰岛素抵抗(HOMA-IR)和Matsuda指数(ISI _(Matsuda))的稳态和全身胰岛素敏感性评估来自OGTT。还收集了其他相关的临床数据。结果共有1612例T2D患者参加该研究,平均年龄为58.67±13.09岁,中位糖尿病持续时间为6年(四分位数,1-10岁)。横跨血清AT3活性的升序,HOMA-IR逐渐减少,而ISI _(Matsuda)逐渐增加(所有P对于趋势& 0.001)。此外,血清AT3活性与HOMA-IR(r = 0.189,P& 0.001)呈负相关,并与ISI _(matsuda)正相关(r = 0.221,p& 0.001)。通过多变量线性回归分析调整其他代谢危险因素,止血参数和降低葡萄糖治疗,HOMA-IR(β= 0.185,T =Δ5.960,P& LT; 0.001)和ISI _(matsuda)(β ?=α.0197,T = 6.632,P& 0.001)仍然与T2D患者的血清AT3活性单独相关。结论基础和全身胰岛素敏感性降低与T2D患者的血清AT3活性降低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号